OSR Health, Inc. (OSRH)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.10
- As of
Kresmion compiles this page from OSRH's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
OSR Health, Inc. (OSRH): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-13.
See the full OSRH dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for OSRH on one page. Preview it with sample data, then open it live with a free account.
Preview the OSRH dossierActive events for OSRH
- medium13F: new position
CITADEL ADVISORS LLC new position in OSRH
- mediumEarnings below estimates
Q4-2025: Missed consensus by 56.9% - EPS $-0.16 vs $-0.102 estimate
FREE, NO ACCOUNT
Every event on OSRH, as it fires
New filings, 13F moves and cross asset events on OSRH land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, OSRH
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on OSRH
OSRH against its peers
OSRH's operating margin of -631.0% ranks in the 50th percentile of 12 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.
| Metric | OSRH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.9M USD | 418189 USD | 62 | 16 |
| Gross margin | 20.4% | 18.9% | 50 | 6 |
| Operating margin | -631.0% | -1170.5% | 50 | 12 |
| Net margin | -931.2% | -465.4% | 46 | 13 |
| Return on equity | -21.3% | -199.6% | 88 | 20 |
| 1 year | -76.3% | -75.9% | 50 | 20 |
Peers (23): SNGX, PULM, NIKI, CANF, CDIO, CNSY, RVPH, EVGN, CELZ, JAGX, PCSA, IMNN, BGMS, CNSP, LGVN, ACXP, AZTR, OTLC, XBIO, SKYE, TCRT, APTOF.D, CSCIF. Left out: ADXN (period gap), ADAPY (no annual filing). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (OSRH: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in OSRH on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on OSRH in the last 180 days.
Upstream: SEC EDGAR filings for OSRH
Kresmion, "OSR Health, Inc. (OSRH) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/OSRH. Upstream data: SEC EDGAR filings for OSRH.
Link to this data (HTML):
<a href="https://kresmion.com/research/OSRH">OSR Health, Inc. (OSRH) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow OSRH on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to OSRH for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.